Literature DB >> 12377741

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

Anastasia Papafili1, Michael R Hill, David J Brull, Robin J McAnulty, Richard P Marshall, Steve E Humphries, Geoffrey J Laurent.   

Abstract

OBJECTIVE: Cyclooxygenase (COX)-2 is a key regulatory enzyme in the synthesis of prostanoids associated with trauma and inflammation. We investigated the COX-2 gene for functional variants that may influence susceptibility to disease. METHODS AND
RESULTS: The promoter of COX-2 was screened for variants in healthy subjects by use of polymerase chain reaction-based methods. Promoter activity was investigated by using reporter expression experiments in human lung fibroblasts. Patients undergoing coronary artery bypass graft surgery, with measurements of plasma markers linked to COX-2 activity, were genotyped for association studies. A common COX-2 promoter variant, -765G>C, was found and shown to be carried by >25% of a group of healthy UK subjects. The -765C allele had significantly lower promoter activity compared with -765G, basally (28+/-3% lower, P<0.005) and in serum-stimulated cells (31+/-2% lower, P<0.005). In patients subjected to coronary artery bypass graft surgery, the magnitude of rise in levels of C-reactive protein (CRP) was strongly genotype dependent. Compared with -765G homozygotes, patients carrying the -765C allele had significantly lower plasma CRP levels at 1 to 4 days after surgery (14% lower at the peak of CRP levels on day 3, P<0.05 for all time points).
CONCLUSIONS: For several acute and chronic inflammatory diseases, -765G>C may influence the variability of response observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377741     DOI: 10.1161/01.atv.0000030340.80207.c5

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  100 in total

1.  Association of COX-2 -765G>C genetic polymorphism with coronary artery disease: a meta-analysis.

Authors:  Ming-Ming Zhang; Xiang Xie; Yi-Tong Ma; Ying-Ying Zheng; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Fen Liu; Bang-Dang Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Michael L Kashon; Victor J Johnson; Zana L Lummus; Kara Fluharty; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Immunotoxicol       Date:  2015-09-04       Impact factor: 3.000

3.  COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.

Authors:  Karen W Makar; Elizabeth M Poole; Alexa J Resler; Brenna Seufert; Karen Curtin; Sarah E Kleinstein; David Duggan; Richard J Kulmacz; Li Hsu; John Whitton; Christopher S Carlson; Christine F Rimorin; Bette J Caan; John A Baron; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2013-12       Impact factor: 2.506

4.  Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  C R Lee; K E North; M S Bray; D J Couper; G Heiss; D C Zeldin
Journal:  Clin Pharmacol Ther       Date:  2007-05-09       Impact factor: 6.875

Review 5.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

6.  Polymorphisms in cyclooxygenase-2 gene in endometrial cancer patients.

Authors:  Federica Torricelli; Vincenzo Dario Mandato; Enrico Farnetti; Martino Abrate; Bruno Casali; Gino Ciarlini; Debora Pirillo; Maria Carolina Gelli; Luigi Costagliola; Davide Nicoli; Stefano Palomba; Giovanni Battista La Sala
Journal:  Tumour Biol       Date:  2015-04-22

7.  Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.

Authors:  Hikmet Akkız; Süleyman Bayram; Aynur Bekar; Ersin Akgöllü; Yakup Ülger
Journal:  Mol Cell Biochem       Date:  2010-11-02       Impact factor: 3.396

Review 8.  The genomic basis of cerebral palsy: a HuGE systematic literature review.

Authors:  M E O'Callaghan; A H MacLennan; E A Haan; G Dekker
Journal:  Hum Genet       Date:  2009-02-24       Impact factor: 4.132

9.  An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.

Authors:  Jason Ross; Linda Lockett; Diana Brookes; Bruce Tabor; Konsta Duesing; Michael Buckley; Trevor Lockett; Peter Molloy; Finlay Macrae; Graeme Young; Ignacio Blanco; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2013-03-27       Impact factor: 4.246

10.  Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Authors:  B R Achyut; Uday C Ghoshal; Nikhil Moorchung; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-09-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.